TPB — Turning Point Brands, Inc.

Summary of TPB Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Consolidated Sales: Up 17% year-over-year to $124.3 million.
• Gross Profit: Increased 14.6% to $68.3 million; gross margin at 55%, down 100 basis points from last year.
• SG&A Expenses: Reported at $55.8 million, up $8 million sequentially, driven by investments in nicotine pouches and marketing.
• Adjusted EBITDA: $25.9 million with a margin of 20.8%, exceeding guidance.
• Modern Oral Segment: Net sales up 133% year-over-year to $52 million; gross revenue up 167% to $69 million, now accounting for 42% of total revenue.
• Zig-Zag Segment: Net sales down 22% year-over-year to $36.7 million; gross profit decreased 18% to $20.9 million.
• Free Cash Flow: Negative $27.4 million, attributed to investments and working capital needs; cash balance at $192.4 million.

2. Strategic Updates and Business Highlights

• Modern Oral Growth: Strong momentum with significant growth in nicotine pouches (FRE and ALP), with plans to increase chain store count by 70% by year-end 2026.
• Manufacturing Investments: Progress on the Louisville facility to localize production and improve supply chain efficiency.
• Marketing Initiatives: Aggressive investment in brand building and partnerships, including a new deal with TKO properties (UFC, Zuffa Boxing, PBR) to enhance brand visibility.
• Sales Force Expansion: Continued investment in sales force and marketing to support distribution and brand awareness.

3. Forward Guidance and Outlook

• Modern Oral Guidance: Gross sales expected to range from $280 million to $300 million, net sales from $210 million to $225 million for the full year 2026.
• EBITDA Guidance: Projected between $70 million to $90 million, reflecting increased investments in growth initiatives.
• CapEx Plans: Budgeted at $4 million to $5 million, with additional spending for PMTAs expected between $3 million to $5 million.

4. Bad News, Challenges, or Points of Concern

• Decline in Zig-Zag Segment: Notable decrease in sales and profits, indicating challenges in maintaining market share.
• High SG&A Expenses: Increased spending on marketing and sales force may pressure margins in the short term.
• Negative Free Cash Flow: Reflects heavy investments, raising concerns about cash management and operational efficiency.
• Market Risks: Competitive pressures in the nicotine pouch market and the need for successful execution of growth strategies amidst a changing regulatory landscape.

5. Notable Q&A Insights

• Chain Wins: The company has secured more chain accounts than initially expected, with rollout expected throughout the year.
• PMTA Process: Management remains cautious but optimistic about the PMTA process, emphasizing the importance of infrastructure in Louisville.
• Consumer Behavior: Rising fuel prices have not significantly impacted consumer behavior in nicotine pouch sales, which are expected to remain resilient.
• Future Sponsorships: Potential for more sponsorships like TKO, but spending will be managed judiciously based on market conditions and sales performance.

Overall, TPB is experiencing strong growth in its Modern Oral segment, supported by strategic investments and partnerships, while facing challenges in other segments and managing cash flow amid aggressive expansion efforts.